NOT-CA-16-014: Notice of Termination of PA-15-264 "Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (Admin Supp)"

Notice of Termination of PA-15-264 "Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (Admin Supp)"

Notice Number: NOT-CA-16-014

Key Dates
Release Date: December 16, 2015

Related Announcements
PA-15-264
PAR-16-056

Issued by
National Cancer Institute (NCI)

Purpose

Effective immediately, the Funding Opportunity Announcement PA-15-264 "Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (Admin Supp)" is terminated.

Applicants are encouraged to refer to PAR-16-056" Revision Applications for Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (U10)".

Inquiries

Please direct all inquiries to:

Tracy Lively, PhD
National Cancer Institute (NCI)
Telephone: 240-276-5944
Email: [email protected]